OBJECTIVE: Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. METHODS: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancer patients and 202 fracture and cataract patients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. RESULTS: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95% CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95% CI, 1.30-16.81) than in subjects with a high SMI. CONCLUSIONS: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.
OBJECTIVE:Arsenic exposure and environmental tobacco smoke (ETS) have been suspected to be associated with bladder cancer risk. We hypothesize that interaction between ETS and the ability to methylate arsenic, a detoxification pathway, modifies the risk of bladder cancer. METHODS: From January 1996 to December 1999, we identified 41 newly diagnosed bladder cancerpatients and 202 fracture and cataractpatients at the National Cheng-Kung University (NCKU) Medical Center. The levels of urinary arsenic species [As(III), As(V), MMA(V), and DMA(V)] were determined in all subjects. RESULTS: We found significant interaction between ETS and secondary methylation index (SMI) on the risk of bladder cancer (p=0.02). Among non-smokers with a high primary methylation index (PMI), the risk of bladder cancer was lower in subjects exposed to ETS (OR, 0.37; 95% CI, 0.14-0.96) than in subjects without exposure to ETS. Among non-smokers without ETS, the risk of bladder cancer was 4.7 times higher in subjects with a low SMI (95% CI, 1.30-16.81) than in subjects with a high SMI. CONCLUSIONS: Ability to methylate arsenic plays an important role in reducing the risk of bladder cancer attributable to the continuation of arsenic exposure from drinking water and from ETS exposure.
Authors: Margaret R Karagas; Tracy Punshon; Matt Davis; Catherine M Bulka; Francis Slaughter; Despina Karalis; Maria Argos; Habibul Ahsan Journal: Curr Environ Health Rep Date: 2019-12
Authors: Jefferey L Burgess; Margaret Kurzius-Spencer; Mary Kay O'Rourke; Sally R Littau; Jason Roberge; Maria Mercedes Meza-Montenegro; Luis Enrique Gutiérrez-Millán; Robin B Harris Journal: J Expo Sci Environ Epidemiol Date: 2012-12-12 Impact factor: 5.563
Authors: Miranda Jones Spratlen; Mary V Gamble; Maria Grau-Perez; Chin-Chi Kuo; Lyle G Best; Joseph Yracheta; Kevin Francesconi; Walter Goessler; Yasmin Mossavar-Rahmani; Meghan Hall; Jason G Umans; Amanda Fretts; Ana Navas-Acien Journal: Food Chem Toxicol Date: 2017-05-04 Impact factor: 6.023
Authors: Catherine W Yeckel; Kathleen M McCarty; Elyssa R Gelmann; Eugen Gurzau; Anca Gurzau; Walter Goessler; Julie Kunrath Journal: Environ Toxicol Pharmacol Date: 2013-10-19 Impact factor: 4.860
Authors: Yen-Ching Chen; David C Christiani; Huey-Jen Jenny Su; Yu-Mei Hsueh; Thomas J Smith; Louise M Ryan; Sheau-Chiou Chao; Julia Yu-Yun Lee; Yue-Liang Leon Guo Journal: Cancer Causes Control Date: 2010-01-19 Impact factor: 2.506